Vault-13

ROYALTY PHARMA PLC

COM · CUSIP 67709Q104

1 institutional holders +0 vs Q4 2022
24,50024.5k shares reported held*
$888.4kreported value*
0 new 1 added 0 reduced 0 sold out net bought ≈ $286.5k (+7.9k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $36.26.

Trends to Q1 2023

Institutional holders

Managers reporting a position, each quarter

001Q4 22: 1Q1 23: 11Q4 22Q1 23
Numbers
QuarterHolders
Q4 20221
Q1 20231

Biggest buyers

Aubrey Capital Management Ltd Added +7,900+7.9k

Biggest sellers

None

Holders, Q1 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Aubrey Capital Management Ltd 0.52% of their portfolio EDINBURGH, X0 24,50024.5k $888.4k $888.4k 0.52% Added +7.9k +7,900